AXOFT
Axoft offers a bioinspired, scalable implant that promotes long-term communication with the nervous system, transforming clinical outcomes, individual health, and the human experience.
AXOFT
Industry:
Electronics Health Care Medical Medical Device Neuroscience Therapeutics
Founded:
2021-06-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.axoft.us
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Content Delivery Network Organization Schema Cloudflare JS CDN JS LocalBusiness Schema BunnyCDN General
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Kymera Therapeutics
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
Pulse Biosciences
Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Intel Ignite
Intel Ignite investment in Non Equity Assistance - Axoft
AIBasis Fund
AIBasis Fund investment in Seed Round - Axoft
Taihill Venture
Taihill Venture investment in Seed Round - Axoft
Castor Ventures
Castor Ventures investment in Seed Round - Axoft
Blindspot Ventures
Blindspot Ventures investment in Seed Round - Axoft
AB Initio Capital Management
AB Initio Capital Management investment in Seed Round - Axoft
Amino Capital
Amino Capital investment in Seed Round - Axoft
Alumni Ventures
Alumni Ventures investment in Seed Round - Axoft
Decent Capital
Decent Capital investment in Seed Round - Axoft
Safar Partners
Safar Partners investment in Seed Round - Axoft
Official Site Inspections
http://www.axoft.us Semrush global rank: 14.96 M Semrush visits lastest month: 30
- Host name: 146.190.184.54
- IP address: 146.190.184.54
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Axoft"
About - Axoft
Redefining health with unparalleled access to neural code. Axoft’s bioinspired, scalable implant promotes long-term communication with the nervous system — transforming clinical …See details»
Axoft - Crunchbase Company Profile & Funding
9,926 Number of Organizations • $616B Total Funding Amount • 59,923 Number of Investors. Track . Massachusetts Companies With Fewer Than 50 Employees (Top 10K) ... Axoft is …See details»
Axoft Launches Brain Implant Technology to Treat …
Oct 18, 2022 Axoft is redefining health with unparalleled access to neural code. Founder Paul Le Floch received the 2021 Forbes 30 under 30 distinction for Science. Find us online at: https://axoft.us/ .See details»
News - Axoft
Axoft has completed the Intel Ignite/US Deep-Tech accelerator program! Jul, 2023 Axoft has graduated from the Creative Destruction Lab program! May, 2023 2022. Axoft Closes $8M …See details»
Neural Implant Startup Axoft Raises $8M | Built In
Oct 21, 2022 Axoft co-founders Jia Liu, CEO Paul Le Floch and CTO Tianyang Ye. | Photo: Axoft. About nine million people die each year of neurological disorders like stroke and …See details»
This Under 30 CEO Is Building Next Generation Brain …
Oct 21, 2022 An Under 30 CEO's company, Axoft, is developing brain implants that could treat disorders such as cerebral palsy. Plus, watch the lifecycle of an Under 30 company, from inception to acquisition ...See details»
Axoft Company Profile - Office Locations, Competitors, Revenue
Axoft is a neurotechnology company that develops brain implant technology. It offers Implant Material, mimicking the soft tissues of the brain; Signal Processing Electronics, for …See details»
Axoft Launches Brain Implant Technology to Treat Long-Term
Oct 18, 2022 This seamless brain-machine interface means less damage to the patient, extended device stability and precise communication with a greater number of neurons. Axoft …See details»
Move Over, Elon: This Under 30 CEO Just Raised $8 …
Oct 18, 2022 Axoft has its origins in Le Floch’s work as a Ph.D. student at Harvard in 2016. At the time, he’d become enamored with new types of soft polymers that had the potential to serve as the basis ...See details»
US NeuroTech Startup Axoft Gets Funded for Brain …
Oct 19, 2022 Axoft’s implants comprise 10,000 times softer materials than flexible electronics and can embed up to 1024 electrodes in a single strand thinner than a credit card. Participation in the FDA Breakthrough Devices …See details»
Axoft Company Profile 2024: Valuation, Funding & Investors
Axoft General Information Description. Developer of implantable electronics designed to amplify brain-machine communication. The company's technology specializes in brain implants made …See details»
Axoft Receives Ethics Committee Approval for First-in-Human …
Nov 24, 2024 PANAMA CITY, Panama, November 24, 2024-- Axoft, Inc. (https://axoft.us/), a pioneer in ultra-soft neural interface technology, has received regulatory ethics committee …See details»
Long-Lasting Neural Implant Can Record From the Brain for Months
Jan 29, 2024 Le Floch is currently the CEO of Axoft, Inc, a company founded in 2021 by Le Floch, Liu and Tianyang Ye, a former graduate student and postdoctoral fellow in the Park …See details»
Axoft announces launch and FDA breakthrough designation for …
Oct 19, 2022 Axoft has announced securing the breakthrough device designation from the US Food and Drug Administration (FDA) for its brain-machine interface (BMI) for the treatment of …See details»
Axoft Launches Brain Implant Technology to Treat Long-Term …
Oct 18, 2022 This seamless brain-machine interface means less damage to the patient, extended device stability and precise communication with a greater number of neurons. Axoft …See details»
Axoft launches ‘soft’ brain-implant technology, gains US FDA ...
Oct 21, 2022 Neurotechnology start-up Axoft has launched and announced US Food and Drug Administration (FDA) Breakthrough Device designation for its brain-machine interface (BMI) …See details»
Solution - Axoft
Solution About Publications News Partner with us / pre-order. A seamless interface with the nervous s y stem The problem we solve. The billions of signals in our nervous system function …See details»
Axoft Scores FDA Designation for Brain-Machine Interface Implant
Oct 18, 2022 Topics; Implantables; Axoft Scores FDA Designation for Brain-Machine Interface Implant. Axoft's implant material enables it to stay functional as the brain shifts or grows, …See details»
Publications - Axoft
Solution About Publications News Partner with us / pre-order. Team contribution to science and technolo g y. SPIE Advanced Lithography + Patterning 04.22.24. Flexible, biocompatible …See details»